組換えヒトアルブミン−ヒト顆粒球コロニー刺激因子融合タンパク質の安定な製剤

摘要

Disclosed are compositions and methods for treating, preventing and ameliorating conditions and diseases characterized by a lowered white blood cell count. The methods and compositions described herein include a fusion polypeptide formed from human serum albumin protein (“HSA”) and human granulocyte-colony stimulating factor (“G-CSF”).